Skip to main content
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 2013 Sep 20;139(11):1961–1962. doi: 10.1007/s00432-013-1507-0

Erratum to: Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective

Thomas C Wehler 1,, Claudine Graf 1, Markus Möhler 2, Jutta Herzog 3, Martin R Berger 4, Ines Gockel 5, Hauke Lang 5, Matthias Theobald 1, Peter R Galle 2, Carl C Schimanski 2,3
PMCID: PMC4079609  PMID: 24052322

Erratum to: J Cancer Res Clin Oncol DOI 10.1007/s00432-013-1483-4

The corresponding author would like to correct the Figs. 1 and 2 and its captions, which were published incorrectly in the original version.

Fig. 1.

Fig. 1

Cetuximab-associated acneiform exanthema. Cetuximab-associated acneiform exanthema is classified according NCI CTCAE3.0

Fig. 2.

Fig. 2

Prophylactic treatment regimen applied to group B and reactive treatment regimen applied to group C

The corrected figures and captions are presented below.

Footnotes

The online version of the original article can be found under doi:10.1007/s00432-013-1483-4.


Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES